Créanciers Commerciaux Changement Date
AstraZeneca USD 22.89B 388M 2026-06
Genmab DKK 116M 110M 2026-06
GlaxoSmithKline GBP 14.34B 7M 2026-06
GRIFOLS EUR 1B 160M 2026-06
Hikma Pharmaceutical USD 715M 104M 2025-12
Lakefront Biotherapeutics EUR 66.35M 29.42M 2026-06
Qiagen NV USD 79.08M 785K 2026-06
UCB EUR 4.04B 755M 2025-12